Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sercan Aksoy

Showing results (91-100 of 206) with videos related to

Pageof 21
Sort By:
Medical Oncology (Northwood, London, England)|October 22, 2010
Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancerNilufer Bulut, Sercan Aksoy, Omer Dizdar, et al.
Talanta|May 31, 2023
Molecularly imprinted electrochemical sensor for the selective and sensitive determination of octreotide in cancer patient plasma sampleEce Ozkan, Göksu Ozcelikay, Elif Damla Gök Topak, et al.
Oral Oncology|December 9, 2021
Results of concurrent radiotherapy and immunotherapy in recurrent and metastatic head and neck cancer: A single-center experienceSezin Yuce Sari, Melek Tugce Yilmaz, Burak Yasin Aktas, et al.
Medical Oncology (Northwood, London, England)|September 13, 2007
Thymic epithelial neoplasia: a study of 58 casesEmin Tamer Elkiran, Huseyin Abali, Sercan Aksoy, et al.
Wiener Klinische Wochenschrift|November 20, 2013
Evaluation of the effect of comorbidity on survival in pancreatic cancer by using "Charlson Comorbidity Index" and "Cumulative Illness Rating Scale"F Tugba Kos, Ozan Yazici, Burak Civelek, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 28, 2015
The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortalityMustafa Solak, Fatma P Turkoz, Ozge Keskin, et al.
Journal of Clinical Medicine|February 27, 2026
Prognostic Value of Baseline Sarcopenia and Adipose Tissue Indices in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors: A Retrospective Cohort StudyLatif Karahan, Arif Akyildiz, Taha Koray Sahin, et al.
Medical Oncology (Northwood, London, England)|April 17, 2008
Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphomaSaadettin Kilickap, Bunyamin Yavuz, Sercan Aksoy, et al.
Current Medical Research and Opinion|February 14, 2013
Trastuzumab emtansine (T-DM1) for HER2-positive breast cancerBaris Boyraz, Mehmet A N Sendur, Sercan Aksoy, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 30, 2013
Evaluation of renal function using the level of neutrophil gelatinase-associated lipocalin is not predictive of nephrotoxicity associated with cisplatin-based chemotherapyF Tugba Kos, Mehmet Ali Nahit Sendur, Sercan Aksoy, et al.
Pageof 21

Showing results (91-100 of 206) with videos related to

Sort By:
Pageof 21
Medical Oncology (Northwood, London, England)|October 22, 2010
Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancerNilufer Bulut, Sercan Aksoy, Omer Dizdar, et al.
Talanta|May 31, 2023
Molecularly imprinted electrochemical sensor for the selective and sensitive determination of octreotide in cancer patient plasma sampleEce Ozkan, Göksu Ozcelikay, Elif Damla Gök Topak, et al.
Oral Oncology|December 9, 2021
Results of concurrent radiotherapy and immunotherapy in recurrent and metastatic head and neck cancer: A single-center experienceSezin Yuce Sari, Melek Tugce Yilmaz, Burak Yasin Aktas, et al.
Medical Oncology (Northwood, London, England)|September 13, 2007
Thymic epithelial neoplasia: a study of 58 casesEmin Tamer Elkiran, Huseyin Abali, Sercan Aksoy, et al.
Wiener Klinische Wochenschrift|November 20, 2013
Evaluation of the effect of comorbidity on survival in pancreatic cancer by using "Charlson Comorbidity Index" and "Cumulative Illness Rating Scale"F Tugba Kos, Ozan Yazici, Burak Civelek, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 28, 2015
The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortalityMustafa Solak, Fatma P Turkoz, Ozge Keskin, et al.
Journal of Clinical Medicine|February 27, 2026
Prognostic Value of Baseline Sarcopenia and Adipose Tissue Indices in HR+/HER2- Metastatic Breast Cancer Treated with CDK4/6 Inhibitors: A Retrospective Cohort StudyLatif Karahan, Arif Akyildiz, Taha Koray Sahin, et al.
Medical Oncology (Northwood, London, England)|April 17, 2008
Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphomaSaadettin Kilickap, Bunyamin Yavuz, Sercan Aksoy, et al.
Current Medical Research and Opinion|February 14, 2013
Trastuzumab emtansine (T-DM1) for HER2-positive breast cancerBaris Boyraz, Mehmet A N Sendur, Sercan Aksoy, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 30, 2013
Evaluation of renal function using the level of neutrophil gelatinase-associated lipocalin is not predictive of nephrotoxicity associated with cisplatin-based chemotherapyF Tugba Kos, Mehmet Ali Nahit Sendur, Sercan Aksoy, et al.
Pageof 21